{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T13:29:44Z","timestamp":1792157384525,"version":"4.4.0"},"reference-count":29,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"9","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2008,5,31]]},"DOI":"10.1097\/qad.0b013e3282fc9c03","type":"journal-article","created":{"date-parts":[[2009,3,5]],"date-time":"2009-03-05T09:02:49Z","timestamp":1236243769000},"page":"1019-1028","source":"Crossref","is-referenced-by-count":56,"title":["Predicting the evolution of Kaposi sarcoma, in the highly active antiretroviral therapy era"],"prefix":"10.1097","volume":"22","author":[{"given":"Emmanuelle","family":"Boffi El Amari","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laurence","family":"Toutous-Trellu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ang\u00e8le","family":"Gayet-Ageron","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michele","family":"Baumann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gieri","family":"Cathomas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ingrid","family":"Steffen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Erb","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicolas J","family":"Mueller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hansjakob","family":"Furrer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthias","family":"Cavassini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pietro","family":"Vernazza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hans H","family":"Hirsch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Enos","family":"Bernasconi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bernard","family":"Hirschel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-3-20210130","first-page":"72","article-title":"Kaposi's sarcoma-associated herpesvirus (KSHV)\/human herpesvirus 8 (HHV-8) as a tumour virus","volume":"10","author":"Cathomas","year":"2003","journal-title":"Herpes"},{"key":"R2-3-20210130","doi-asserted-by":"crossref","first-page":"1865","DOI":"10.1126\/science.7997879","article-title":"Identification of herpesvirus-like DNA sequences in AIDS-associated Kaposi's sarcoma","volume":"266","author":"Chang","year":"1994","journal-title":"Science"},{"key":"R3-3-20210130","doi-asserted-by":"crossref","first-page":"2644","DOI":"10.1002\/cncr.20309","article-title":"The changing pattern of Kaposi sarcoma in patients with HIV, 1994\u20132003","volume":"100","author":"Mocroft","year":"2004","journal-title":"Cancer"},{"key":"R4-3-20210130","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1097\/00002030-200103300-00013","article-title":"Decreasing rates of Kaposi's sarcoma and non-Hodgkin's lymphoma in the era of potent combination antiretroviral therapy","volume":"15","author":"Grulich","year":"2001","journal-title":"AIDS"},{"key":"R5-3-20210130","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1097\/00126334-200007010-00013","article-title":"Incidence and trends in Kaposi's sarcoma in the era of effective antiretroviral therapy","volume":"24","author":"Jones","year":"2000","journal-title":"J Acquir Immune Defic Syndr"},{"key":"R6-3-20210130","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1097\/00002030-200402200-00015","article-title":"Short- and long-term effects of highly active antiretroviral therapy on Kaposi sarcoma-associated herpesvirus immune responses and viraemia","volume":"18","author":"Bourboulia","year":"2004","journal-title":"AIDS"},{"key":"R7-3-20210130","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1016\/S1470-2045(03)01192-6","article-title":"Use of HIV protease inhibitors to block Kaposi's sarcoma and tumour growth","volume":"4","author":"Sgadari","year":"2003","journal-title":"Lancet Oncol"},{"key":"R8-3-20210130","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1038\/nm0302-225","article-title":"HIV protease inhibitors are potent antiangiogenic molecules and promote regression of Kaposi sarcoma","volume":"8","author":"Sgadari","year":"2002","journal-title":"Nat Med"},{"key":"R9-3-20210130","doi-asserted-by":"crossref","first-page":"2876","DOI":"10.1200\/JCO.2003.10.162","article-title":"AIDS-related Kaposi's sarcoma: evaluation of potential new prognostic factors and assessment of the AIDS Clinical Trial Group Staging System in the HAART Era \u2013 the Italian Cooperative Group on AIDS and Tumors and the Italian Cohort of Patients Naive From Antiretrovirals","volume":"21","author":"Nasti","year":"2003","journal-title":"J Clin Oncol"},{"key":"R10-3-20210130","doi-asserted-by":"crossref","first-page":"2440","DOI":"10.1002\/cncr.11816","article-title":"Impact of highly active antiretroviral therapy on the presenting features and outcome of patients with Acquired Immunodefiency Syndrome-related Kaposi","volume":"98","author":"Nasti","year":"2003","journal-title":"Cancer"},{"key":"R11-3-20210130","doi-asserted-by":"crossref","first-page":"916","DOI":"10.1002\/ijc.10274","article-title":"Effect of highly active antiretroviral therapy on survival among HIV-infected men with Kaposi sarcoma or non-Hodgkin lymphoma","volume":"98","author":"Tam","year":"2002","journal-title":"Int J Cancer"},{"key":"R12-3-20210130","doi-asserted-by":"crossref","first-page":"3085","DOI":"10.1200\/JCO.1997.15.9.3085","article-title":"AIDS-related Kaposi's sarcoma: prospective validation of the AIDS Clinical Trials Group staging classification. AIDS Clinical Trials Group Oncology Committee","volume":"15","author":"Krown","year":"1997","journal-title":"J Clin Oncol"},{"key":"R13-3-20210130","doi-asserted-by":"crossref","first-page":"858","DOI":"10.1046\/j.0022-202x.2001.01465.x","article-title":"Virologic and immunologic parameters that predict clinical response of AIDS-associated Kaposi's sarcoma to highly active antiretroviral therapy","volume":"117","author":"Pellet","year":"2001","journal-title":"J Invest Dermatol"},{"key":"R14-3-20210130","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1097\/00126334-200212010-00003","article-title":"Prospective study of the effects of antiretroviral therapy on Kaposi sarcoma\u2013associated herpesvirus infection in patients with and without Kaposi sarcoma","volume":"31","author":"Gill","year":"2002","journal-title":"J Acquir Immune Defic Syndr"},{"key":"R15-3-20210130","doi-asserted-by":"crossref","first-page":"1580","DOI":"10.1097\/00002030-200307040-00028","article-title":"Relapse of Kaposi's sarcoma in HIV-infected patients switching from a protease inhibitor to a nonnucleoside reverse transcriptase inhibitor-based highly active antiretroviral therapy regimen","volume":"17","author":"Bani-Sadr","year":"2003","journal-title":"AIDS"},{"key":"R16-3-20210130","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.1200\/JCO.1989.7.9.1201","article-title":"Kaposi's sarcoma in the acquired immune deficiency syndrome: a proposal for uniform evaluation, response, and staging criteria. AIDS Clinical Trials Group Oncology Committee","volume":"7","author":"Krown","year":"1989","journal-title":"J Clin Oncol"},{"key":"R17-3-20210130","first-page":"415","article-title":"Distribution of human herpesvirus 8 DNA in tumorous and nontumorous tissue of patients with acquired immunodeficiency syndrome with and without Kaposi's sarcoma","volume":"11","author":"Cathomas","year":"1998","journal-title":"Mod Pathol"},{"key":"R18-3-20210130","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1097\/01.pas.0000186397.18206.1b","article-title":"Increased rate of Helicobacter pylori infection detected by PCR in biopsies with chronic gastritis","volume":"30","author":"Zsikla","year":"2006","journal-title":"Am J Surg Pathol"},{"key":"R19-3-20210130","doi-asserted-by":"crossref","first-page":"5488","DOI":"10.1128\/JCM.41.12.5488-5491.2003","article-title":"Human herpesvirus 8 load in matched serum and plasma samples of patients with AIDS-associated Kaposi's sarcoma","volume":"41","author":"Polstra","year":"2003","journal-title":"J Clin Microbiol"},{"key":"R20-3-20210130","doi-asserted-by":"crossref","first-page":"2282","DOI":"10.1097\/00002030-200009290-00006","article-title":"Relationship of human herpesvirus 8 peripheral blood virus and Kaposi's sarcoma clinical stage","volume":"14","author":"Campbell","year":"2000","journal-title":"AIDS"},{"key":"R21-3-20210130","doi-asserted-by":"crossref","first-page":"2109","DOI":"10.1002\/cncr.22236","article-title":"Virologic, hematologic and immunologic risk factors for classic Kaposi sarcoma","volume":"107","author":"Brown","year":"2006","journal-title":"Cancer"},{"key":"R22-3-20210130","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1002\/jmv.20167","article-title":"Comparison of serologic responses between Kaposi' sarcoma-positive and -negative Men who were seropositive for both HHV8 and HIV","volume":"74","author":"Inoue","year":"2004","journal-title":"J Med Virol"},{"key":"R23-3-20210130","doi-asserted-by":"crossref","first-page":"858","DOI":"10.1016\/S0140-6736(96)03240-0","article-title":"Antibodies to human herpesvirus type 8 in the general population and in Kaposi's sarcoma patients","volume":"348","author":"Lennette","year":"1996","journal-title":"Lancet"},{"key":"R24-3-20210130","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1002\/jmv.1031","article-title":"Longitudinal sero-reactivity to human herpesvirus 8 (KSHV) in the Swiss HIV Cohort 4.7 years before KS","volume":"64","author":"Quinlivan","year":"2001","journal-title":"J Med Virol"},{"key":"R25-3-20210130","doi-asserted-by":"crossref","first-page":"1940","DOI":"10.1086\/315503","article-title":"Interaction of human immunodeficiency virus type 1 and human herpesvirus type 8 infections on the incidence of Kaposi's sarcoma","volume":"181","author":"Jacobson","year":"2000","journal-title":"J Infect Dis"},{"key":"R26-3-20210130","doi-asserted-by":"crossref","first-page":"1495","DOI":"10.1016\/S0140-6736(06)68649-2","article-title":"A prognostic index for AIDS-associated Kaposi's sarcoma in the era of highly active antiretroviral therapy","volume":"367","author":"Stebbing","year":"2006","journal-title":"Lancet"},{"key":"R27-3-20210130","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/S1473-3099(02)00263-3","article-title":"Update on Kaposi's sarcoma and other HHV8 associated diseases. Part 1: epidemiology, environmental predispositions, clinical manifestations, and therapy","volume":"2","author":"Hengge","year":"2002","journal-title":"Lancet Infect Dis"},{"key":"R28-3-20210130","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1016\/S1473-3099(02)00288-8","article-title":"Update on Kaposi's sarcoma and other HHV8 associated diseases. Part 2: pathogenesis, Castleman's disease, and pleural effusion lymphoma","volume":"2","author":"Hengge","year":"2002","journal-title":"Lancet Infect Dis"},{"key":"R29-3-20210130","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.1086\/507648","article-title":"Low T cell responses to human herpesvirus 8 in patients with AIDS-related and classic Kaposi sarcoma","volume":"194","author":"Guihot","year":"2006","journal-title":"J Infect Dis"}],"container-title":["AIDS"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/00002030-200805310-00003","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T17:39:01Z","timestamp":1786037941000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00002030-200805310-00003"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,5,31]]},"references-count":29,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2008]]}},"URL":"https:\/\/doi.org\/10.1097\/qad.0b013e3282fc9c03","relation":{},"ISSN":["0269-9370"],"issn-type":[{"value":"0269-9370","type":"print"}],"subject":[],"published":{"date-parts":[[2008,5,31]]}}}